Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant

By Gupta A.   Pal R.   Ahlawat S.   Bhatia P.   Singh O.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3384-3389

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses

By Somani J.   Lonial S.   Rosenthal H.   Resnick S.   Kakhniashvili I.   Waller E.K.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 221-230

Elsevier

Access to resources Recommend Favorite

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains

By Babai I.   Barenholz Y.   Zakay-Rones Z.   Greenbaum E.   Samira S.   Hayon I.   Rochman M.   Kedar E.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 505-515

Elsevier

Access to resources Recommend Favorite

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

By Santos W.R.   de Lima V.M.F.   de Souza E.P.   Bernardo R.R.   Palatnik M.   de Sousa C.B.P.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 30-43

Elsevier

Access to resources Recommend Favorite

Increased immunogenicity of HIV envelope subunit complexed with 2 -macroglobulin when combined with monophosphoryl lipid A and GM-CSF

By Liao H.-X.   Cianciolo G.J.   Staats H.F.   Scearce R.M.   Lapple D.M.   Stauffer S.H.   Thomasch J.R.   Pizzo S.V.   Montefiori D.C.   Hagen M.   Eldridge J.   Haynes B.F.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2396-2403

Elsevier

Access to resources Recommend Favorite